Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus
2018 ◽
Vol 38
(9)
◽
pp. 2198-2206
◽
2008 ◽
Vol 81
(3)
◽
pp. 338-344
◽
Keyword(s):
2004 ◽
Vol 17
(6)
◽
Keyword(s):
Keyword(s):